Last update 08 May 2025

FAB 117-HC

Overview

Basic Info

Drug Type
Mesenchymal stem cell therapy
Synonyms
Target-
Action-
Mechanism
Cell replacements
Therapeutic Areas
Nervous System DiseasesOther Diseases
Active Indication-
Inactive Indication
Spinal Cord InjuriesTraumatic spinal cord injury
Originator Organization
1st Biotherapeutics, Inc.1st Biotherapeutics, Inc.
Histocell SLHistocell SL
Active Organization-
Inactive Organization
Histocell SLHistocell SL1st Biotherapeutics, Inc.1st Biotherapeutics, Inc.
License Organization-
Drug Highest PhasePendingPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with FAB 117-HC
NCT02917291
/ Unknown statusPhase 1/2
Clinical Trial of Phase 1/2 to Evaluate the Feasibility, Safety, Tolerability and Preliminary Efficacy of the Administration of FAB117-HC, a Drug Whose Active Ingredient is HC016, Allogeneic Adipose Derived Adult Mesenchymal Stem Cells Expanded and Pulsed With H2O2, in Acute Traumatic SCI Patients.
100 Clinical Results associated with FAB 117-HC
Login to view more data
100 Translational Medicine associated with FAB 117-HC
Login to view more data
100 Patents (Medical) associated with FAB 117-HC
Login to view more data
100 Deals associated with FAB 117-HC
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Traumatic spinal cord injuryPhase 2
Spain
Histocell SLHistocell SL
01 Dec 2016
Spinal Cord InjuriesPhase 2
Spain
1st Biotherapeutics, Inc.1st Biotherapeutics, Inc.
10 Nov 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free